Baveno VII–renewing consensus in portal hypertension

…, X Luo, M Mandorfer, SD Murad, V Paradis, D Patch… - Journal of …, 2022 - Elsevier
To expand on the work of previous meetings, a virtual Baveno VII workshop was organised
for October 2021. Among patients with compensated cirrhosis or compensated advanced …

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies

…, N Davies, J Tibballs, T Meyer, DW Patch… - Cardiovascular and …, 2007 - Springer
Background Chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular
carcinoma (HCC). The optimal schedule, or whether embolization (TAE) alone gives …

[HTML][HTML] Prednisolone or pentoxifylline for alcoholic hepatitis

…, A McCune, J Mellor, J O'Grady, D Patch… - … England Journal of …, 2015 - Mass Medical Soc
Background Alcoholic hepatitis is a clinical syndrome characterized by jaundice and liver
impairment that occurs in patients with a history of heavy and prolonged alcohol use. The short-…

[HTML][HTML] Phase 1–2 trial of AAVS3 gene therapy in patients with hemophilia B

…, MR Peralta, M Quaye, DW Patch… - … England Journal of …, 2022 - Mass Medical Soc
Background FLT180a (verbrinacogene setparvovec) is a liver-directed adeno-associated
virus (AAV) gene therapy that uses a synthetic capsid and a gain-of-function protein to …

[HTML][HTML] Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis

…, A Escorsell, JC Garcia-Pagan, D Patch… - … England Journal of …, 2005 - Mass Medical Soc
Background Nonselective beta-adrenergic blockers decrease portal pressure and prevent
variceal hemorrhage. Their effectiveness in preventing varices is unknown. Methods We …

Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis

…, A Escorsell, JC Garcia–Pagan, R Makuch, D Patch… - Gastroenterology, 2007 - Elsevier
Background & Aims: Our aim was to identify predictors of clinical decompensation (defined
as the development of ascites, variceal hemorrhage [VH], or hepatic encephalopathy [HE]) in …

UK guidelines on the management of variceal haemorrhage in cirrhotic patients

D Tripathi, AJ Stanley, PC Hayes, D Patch, C Millson… - Gut, 2015 - gut.bmj.com
These updated guidelines on the management of variceal haemorrhage have been
commissioned by the Clinical Services and Standards Committee (CSSC) of the British Society of …

Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US

…, GD Kirk, RC Patel, S Safo, DA Patch… - JAMA internal …, 2022 - jamanetwork.com
Importance Persons with immune dysfunction have a higher risk for severe COVID-19 outcomes.
However, these patients were largely excluded from SARS-CoV-2 vaccine clinical trials…

[HTML][HTML] Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

…, DC Wheeler, J O'Beirne, D Thorburn, D Patch… - The Lancet, 2011 - thelancet.com
Background Cytomegalovirus end-organ disease can be prevented by giving ganciclovir
when viraemia is detected in allograft recipients. Values of viral load correlate with …

[PDF][PDF] Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage

J Goulis, A Armonis, D Patch, C Sabin… - …, 1998 - Wiley Online Library
Bacterial infection is frequently diagnosed in cirrhotic patients with variceal hemorrhage.
The aim of this study was to assess the incidence of failure to control bleeding in cirrhotic …